The Carlyle Group beat several large strategic players in the race to acquire Czechia’s Meopta Optika, one of the winners in the booming semiconductor market, with a novel approach to financing one of the deciding factors. The private equity firm now wants to combine Meopta’s expertise with its compatriot Tescan Orsay to solve one of the biggest difficulties facing the microchip sector, managing directors Carlyle’s Friedel Drees and Vladimir Lasocki told PE Hub Europe.
Carlyle scopes out microchip inspection with Meopta and Tescan
Marrying the competencies of the Czech companies to build electron components at scale is 'potentially a big deal', says Carlyle’s Vladimir Lasocki.
